DivestmentJul 8, 2026, 08:07 AM
Azenta Completes $63M Sale of B Medical Systems
AI Summary
Azenta, Inc. announced the completion of the sale of its B Medical Systems business to Thelema S.à r.l. for a fixed purchase price of $63 million. The transaction, which closed on July 1, 2026, included $28 million in cash and a $35 million secured vendor loan provided by an Azenta subsidiary to Thelema. This divestment aligns with Azenta's strategy to focus on its core life sciences businesses and enhance financial flexibility.
Key Highlights
- Azenta completed the sale of B Medical Systems S.à r.l. to Thelema S.à r.l. for $63 million.
- The purchase price consisted of $28 million cash and a $35 million secured vendor loan.
- The vendor loan bears interest at 6.0% per annum and matures in three months.
- The loan is a related party transaction, approved by the Audit Committee.
- The transaction is expected to result in a pro forma decrease of $41.464 million in retained earnings.
- Pro forma cash and cash equivalents increased by $19 million due to the net cash proceeds.
Price Impact
More from AZTA
Quarterly ResultMay 8, 8:12 AM
Azenta Q2 Net Loss $(160.8)M; Goodwill Impairment $149.1M
Quarterly ResultMay 5, 4:47 PM
Azenta Q2 Revenue $145M; FY26 Guidance Lowered; LRP Extended to 2029
Management ChangeApr 7, 8:31 AM
Azenta Announces Management Change: William Martin Appointed President of Multiomics Business, Ginger Zhou Steps Down